Antisense modulation of PTP1B expression
US7563884B2 · kind B2 · utility
24Cited by
7References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2004 |
| Grant date | Jul 21, 2009 |
| Priority date | — |
| Expiry date | Jun 9, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.